Literature DB >> 15364440

Comparative immunogenicity analysis of modified vaccinia Ankara vectors expressing native or modified forms of hepatitis C virus E1 and E2 glycoproteins.

Jean-Daniel Abraham1, Nourredine Himoudi, François Kien, Jean-Luc Berland, Audrey Codran, Birke Bartosch, Thomas Baumert, Glaucia Paranhos-Baccala, Catherine Schuster, Geneviève Inchauspé, Marie Paule Kieny.   

Abstract

We have evaluated in C57/Bl6 and HLA-A2.1 transgenic mice the immunogenicity of three MVA vectors expressing either native HCV E1E2 polyprotein, truncated and secreted E1 (E'1(311)) and E2 (E'2(661)) proteins, or a chimeric E1E2 heterodimer presented at the plasma membrane. Immunization induced mainly a Th1 response in HLA-A2.1 transgenic mice while a Th2-type response was detected in C57/Bl6 mice. Comparison of the three vectors shows an increase in the humoral response when antigens are secreted or membrane bound, and slightly in the cellular response when antigens are exposed on the cell surface.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15364440     DOI: 10.1016/j.vaccine.2004.04.005

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

Review 1.  Vaccines to prevent chronic hepatitis C virus infection: current experimental and preclinical developments.

Authors:  Philip Wintermeyer; Jack R Wands
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

2.  Broadly neutralizing immune responses against hepatitis C virus induced by vectored measles viruses and a recombinant envelope protein booster.

Authors:  Jorge Reyes-del Valle; Cynthia de la Fuente; Mallory A Turner; Christoph Springfeld; Swapna Apte-Sengupta; Marie E Frenzke; Amelie Forest; Jillian Whidby; Joseph Marcotrigiano; Charles M Rice; Roberto Cattaneo
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

3.  Elicitation of strong immune responses by a DNA vaccine expressing a secreted form of hepatitis C virus envelope protein E2 in murine and porcine animal models.

Authors:  Yi-Ping Li; Hye-Na Kang; Lorne-A Babiuk; Qiang Liu
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

4.  High, broad, polyfunctional, and durable T cell immune responses induced in mice by a novel hepatitis C virus (HCV) vaccine candidate (MVA-HCV) based on modified vaccinia virus Ankara expressing the nearly full-length HCV genome.

Authors:  Carmen E Gómez; Beatriz Perdiguero; María Victoria Cepeda; Lidia Mingorance; Juan García-Arriaza; Andrea Vandermeeren; Carlos Óscar S Sorzano; Mariano Esteban
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

5.  Evidence for protection against chronic hepatitis C virus infection in chimpanzees by immunization with replicating recombinant vaccinia virus.

Authors:  Jin-Won Youn; Yu-Wen Hu; Nancy Tricoche; Wolfram Pfahler; Mohamed Tarek Shata; Marlene Dreux; François-Loic Cosset; Antonella Folgori; Dong-Hun Lee; Betsy Brotman; Alfred M Prince
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

6.  Prophylactic and Therapeutic Vaccination against Hepatitis C Virus (HCV): Developments and Future Perspectives.

Authors:  Marian E Major
Journal:  Viruses       Date:  2009-08-12       Impact factor: 5.048

Review 7.  The evolution of poxvirus vaccines.

Authors:  Lucas Sánchez-Sampedro; Beatriz Perdiguero; Ernesto Mejías-Pérez; Juan García-Arriaza; Mauro Di Pilato; Mariano Esteban
Journal:  Viruses       Date:  2015-04-07       Impact factor: 5.048

8.  A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice.

Authors:  Makutiro Ghislain Masavuli; Danushka K Wijesundara; Alexander Underwood; Dale Christiansen; Linda Earnest-Silveira; Rowena Bull; Joseph Torresi; Eric J Gowans; Branka Grubor-Bauk
Journal:  Front Immunol       Date:  2019-05-24       Impact factor: 7.561

9.  BacMam virus-based surface display for HCV E2 glycoprotein induces strong cross-neutralizing antibodies and cellular immune responses in vaccinated mice.

Authors:  Ebrahim Kord; Farzin Roohvand; Jean Dubuisson; Thibaut Vausselin; Hosein Nasr Azadani; Abolfazl Keshavarz; Ahmad Nejati; Katayoun Samimi-Rad
Journal:  Infect Agent Cancer       Date:  2021-12-18       Impact factor: 2.965

10.  Conserved peptides within the E2 region of Hepatitis C virus induce humoral and cellular responses in goats.

Authors:  Mostafa K El-Awady; Ashraf A Tabll; Yasmine S El-Abd; Hassan Yousif; Mohsen Hegab; Mohamed Reda; Reem El Shenawy; Rehab I Moustafa; Nabila Degheidy; Noha G Bader El Din
Journal:  Virol J       Date:  2009-05-27       Impact factor: 4.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.